A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : LAK

Search Conditions:
Search Keyword : LAK
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: LAK
Appearance Frequency: 2311 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
lymphokine-activated killer
(2261 times)
Allergy and Immunology
(785 times)
IL-2 (669 times)
NK (669 times)
rIL-2 (252 times)
1982 Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
IL-2-activated killer
(12 times)
Allergy and Immunology
(6 times)
NK (3 times)
IL-2 (2 times)
AM (1 time)
1987 Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cells.
interleukin 2-activated killer
(5 times)
Neoplasms
(3 times)
NK (2 times)
ADM (1 time)
IL-2 (1 time)
1988 Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitro.
Local Anesthesia plus ketamine
(3 times)
Dentistry
(2 times)
LAA (2 times)
CNS (1 time)
NMDA (1 time)
2009 Assessment of combined local anesthesia and ketamine for pain, swelling, and trismus after surgical extraction of third molars.
lichenoid actinic keratosis
(2 times)
Pathology
(2 times)
LP (2 times)
LPLK (2 times)
LC (1 time)
1993 Immunohistochemistry detects differences between lichen planus-like keratosis, lichen planus, and lichenoid actinic keratosis.
lock-and-key
(2 times)
Chemistry Techniques, Analytical
(2 times)
Trz (2 times)
BVES (1 time)
GST I (1 time)
2006 Lock-and-key motif as a concept for designing affinity adsorbents for protein purification.
Lymphokine (i.e., interleukin 2; IL-2)-activated killer
(2 times)
Allergy and Immunology
(2 times)
SEM (1 time)
1988 Long-term cultivation of functional human macrophages in Teflon dishes with serum-free media.
lymphokine induced activated killer cell
(2 times)
Allergy and Immunology
(2 times)
ASGM1 (1 time)
CTL (1 time)
HCV (1 time)
1987 Differential expression of asialo GM1 on alloreactive cytotoxic T lymphocytes and lymphokine-activated killer cells.
lymphokine-activated killer lymphocytes
(2 times)
Neoplasms
(2 times)
DC (1 time)
DRHBT (1 time)
2009 Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
10  IL-2 activated killer cell activity
(1 time)
Pharmacology
(1 time)
IL-2 (1 time)
PAP-I (1 time)
1995 Effects of Phytolacca acinosa polysaccharides I combined with interleukin-2 on the cytotoxicity of murine splenocytes against tumor cells.
11  lines inhibited NK (by > 95%) and interleukin 2-activated killer
(1 time)
Allergy and Immunology
(1 time)
anti-beta (1 time)
eATP (1 time)
NK (1 time)
1994 A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines.
12  lines to IL-2 activated killer
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
CCDT (1 time)
GST (1 time)
1999 Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy.
13  lipase AK
(1 time)
Biochemistry
(1 time)
LPS (1 time)
2017 Synthetically useful variants of industrial lipases from Burkholderia cepacia and Pseudomonas fluorescens.
14  Local Alignment Kernel
(1 time)
Medical Informatics
(1 time)
BLAST (1 time)
LZW (1 time)
SVMs (1 time)
2018 LZW-Kernel: fast kernel utilizing variable length code blocks from LZW compressors for protein sequence classification.
15  Lower acute kyphosis
(1 time)
Medicine
(1 time)
--- 2009 Circumferential thoracolumbar corrective fusion with an anterior interbody fresh-frozen femoral head allograft for osteoporotic lower acute kyphosis: a case report.
16  lymph nodes of mice show increased IL-2 activated killer
(1 time)
Allergy and Immunology
(1 time)
--- 1987 Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.
17  lymphocyte and interleukin-2-activated lymphocyte
(1 time)
Vascular Diseases
(1 time)
MHC (1 time)
sFn (1 time)
2008 Soluble fibrin inhibits lymphocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis and immunotherapy.
18  lymphocyte sub-population termed 'Lymphokine Activated Killer
(1 time)
Neoplasms
(1 time)
IL-2 (1 time)
1988 [LAK cells and immunotherapy of cancer].
19  lymphokine AK
(1 time)
Allergy and Immunology
(1 time)
AK (1 time)
T3AK (1 time)
1988 Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
20  lymphokine natural killer cell activity
(1 time)
Medicine
(1 time)
cGVHD (1 time)
LP (1 time)
1997 Immunophenotyping as a diagnostic tool to differentiate lichen planus from chronic graft-versus-host disease: diagnostic observations on two patients.
21  lymphokine-activated natural killer
(1 time)
Communicable Diseases
(1 time)
IFN-gamma (1 time)
IL (1 time)
1996 Lymphokine-activated killer cells lyse Listeria-infected hepatocytes and produce elevated quantities of interferon-gamma.
22  lymphokine-activated non-MHC-restricted killing
(1 time)
Allergy and Immunology
(1 time)
BM (1 time)
LGL (1 time)
MC (1 time)
1993 Effect of various cytokine combinations on induction of non-MHC-restricted cytotoxicity.
23  Lymphokine-Activating-Killer cell
(1 time)
Hematology
(1 time)
ALL (1 time)
AML (1 time)
CR (1 time)
1998 A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia.
24  lysability by interleukin-2 activated lymphocytes
(1 time)
Biochemistry
(1 time)
--- 1992 CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes.
25  lysis by activated and non-activated killer
(1 time)
Allergy and Immunology
(1 time)
--- 1989 A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity.
26  lysis by interleukin-2-activated natural killer cells
(1 time)
Hematology
(1 time)
AML (1 time)
GM-CSF (1 time)
ICAM-1, CD54 (1 time)
1995 GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
27  lysis mediated by interleukin-2(IL-2)-activated killer cells
(1 time)
Allergy and Immunology
(1 time)
HCMV (1 time)
HFF (1 time)
IL-2 (1 time)
1994 Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: interferon-beta-mediated target cell protection does not correlate with up-regulation of HLA class I surface molecules.
28  lysis of normal autologous monocytes by interleukin-2-activated killer
(1 time)
Neoplasms
(1 time)
mAbs (1 time)
1990 Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets.
29  rIL 2-activated killer cells
(1 time)
Allergy and Immunology
(1 time)
CD3 (1 time)
rIL-2 (1 time)
1987 Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.